当前位置: X-MOL 学术J Chromatogr Sci › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Risk and DoE-Based Analytical Failure Mode Effect Analysis (AFMEA) to Simultaneous Estimation of Montelukast Sodium and Bilastine by HPTLC Method Using Enhanced AQbD Approach
Journal of Chromatographic Science ( IF 1.5 ) Pub Date : 2021-08-17 , DOI: 10.1093/chromsci/bmab107
Pintu Prajapati 1 , Jayesh Tamboli 1 , Ashish Mishra 1
Affiliation  

The fixed-dose combination (FDC) of montelukast sodium (MLS) and bilastine (BIL) is used for monotherapy in the patient with seasonal allergic rhinoconjuctivitis and asthma. According to the upcoming ICH (International Council for Harmonization) Q14 guideline, the development of the analytical method by the implementation of the Analytical Quality by Design (AQbD) approach based on principles of Quality Risk Management (QRM) and design of experiments (DoE) would be a regulatory requirement for the registration of new drug substance and product in ICH countries. Hence, a robust high-performance thin layer chromatography method has been developed, which was not previously reported for simultaneous estimation of MLS and BIL using risk and DoE-based enhanced AQbD approach. The analytical failure mode effect analysis (AFMEA) was started with the identification of potential analytical failure modes followed by their effect analysis by RPN ranking and filtering method. The DoE-based AFMEA was applied for optimization of high-risk analytical failure modes by central composite design using Design-Expert software. The method operable design ranges and control strategy was set for quality risk management throughout the lifecycle of the developed method. The developed method was validated as per ICH Q2 (R1) guideline. The method was applied for the assay of FDC, and results were found in compliance with the labeled claim.

中文翻译:

基于风险和 DoE 的分析失效模式效应分析 (AFMEA),通过 HPTLC 方法使用增强的 AQbD 方法同时估计孟鲁司特钠和比拉斯汀

孟鲁司特钠 (MLS) 和比拉斯汀 (BIL) 的固定剂量组合 (FDC) 用于季节性过敏性鼻结膜炎和哮喘患者的单药治疗。根据即将发布的 ICH(国际协调委员会)Q14 指南,通过实施基于质量风险管理 (QRM) 和实验设计 (DoE) 原则的分析质量设计 (AQbD) 方法来开发分析方法将成为 ICH 国家新原料药和产品注册的监管要求。因此,已经开发出一种稳健的高性能薄层色谱方法,以前没有报道过使用风险和基于 DoE 的增强 AQbD 方法同时估计 MLS 和 BIL。分析失效模式影响分析 (AFMEA) 从识别潜在的分析失效模式开始,然后通过 RPN 排序和过滤方法对其影响进行分析。基于 DoE 的 AFMEA 被应用于使用 Design-Expert 软件通过中央复合设计优化高风险分析故障模式。制定了方法可操作设计范围和控制策略,用于在所开发方法的整个生命周期内进行质量风险管理。所开发的方法已根据 ICH Q2 (R1) 指南进行了验证。该方法应用于FDC的测定,结果符合标签要求。基于 DoE 的 AFMEA 被应用于使用 Design-Expert 软件通过中央复合设计优化高风险分析故障模式。制定了方法可操作设计范围和控制策略,用于在所开发方法的整个生命周期内进行质量风险管理。所开发的方法已根据 ICH Q2 (R1) 指南进行了验证。该方法应用于FDC的测定,结果符合标签要求。基于 DoE 的 AFMEA 被应用于使用 Design-Expert 软件通过中央复合设计优化高风险分析故障模式。制定了方法可操作设计范围和控制策略,用于在所开发方法的整个生命周期内进行质量风险管理。所开发的方法已根据 ICH Q2 (R1) 指南进行了验证。该方法应用于FDC的测定,结果符合标签要求。
更新日期:2021-08-17
down
wechat
bug